Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
Injection Peptide Drug Market contains market size and forecasts of Injection Peptide Drug in Global, including the following market information:
- Global Injection Peptide Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Injection Peptide Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injection Peptide Drug include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injection Peptide Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injection Peptide Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Injection Peptide Drug Market Segment Percentages, by Type, 2021 (%)
- Intravenous Injection
- Subcutaneous Injection
Global Injection Peptide Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Injection Peptide Drug Market Segment Percentages, by Application, 2021 (%)
- Cancer
- Metabolic Disorders
- Central Nervous System
- Other
Global Injection Peptide Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Injection Peptide Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Injection Peptide Drug revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Injection Peptide Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- Teva
- Novo Nordisk
- Takeda
- Eli Lilly
- AstraZeneca
- Novartis
- AbbVie
- Ipsen
- Ferring
- Merck
- The Medicines
- J & J
Industry Market Size
